Drug Channels

APRIL 12, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence. Read on for Jessica’s insights.

Drugs 98

Drugs 98

Drug Channels

MAY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, join Chris on May 21 at 1:00 p.m. ET for a free online panel discussion about how brands can continue to offer robust patient support despite IRA challenges. Read on for Chris’ insights. All rights reserved.

Marketing 98

Marketing Drugs 98

Drug Channels

APRIL 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. All rights reserved.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 22, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He then explains three ways that specialty pharmaceutical companies can use digital intake strategies to speed patient enrollment. Read on for Adam’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Therapies Drugs 98

Drug Channels

MARCH 8, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To request an analysis of your copay savings program and learn more about Paysign’s patient affordability solutions, contact affordability@paysign.com or visit paysign.com/rx. Read on for Logan’s insights. All rights reserved.

Drugs 97

Drugs 97

Drug Channels

APRIL 26, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit. To keep up with CoverMyMeds and all the action at Asembia, click here to sign up for daily recaps from Asembia. Read on for Kevin’s insights. All rights reserved.

Therapies 96

Therapies Drugs 96

Drug Channels

FEBRUARY 23, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She outlines four success factors for manufacturers that use a digital hub partner. To learn more, register for Phil's upcoming webinar: Improving Access, Coverage, and GTN with a Digital Hub. Read on for Nicole’s insights.

Drugs 98

Drugs 98

Drug Channels

JULY 19, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, read EVERSANA’s free report: IDN Trends and Engagement Strategies Every Drug Manufacturer Needs to Know. Read on for Greg, Krista, and Faruk’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Production 52

Production Drugs 52

Drug Channels

MAY 14, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Chalk off these coinsurance surprises to yet another unintended consequence of the IRA. Seniors who are expecting to see costs drop may find they are instead being taken for a rollercoaster ride. All rights reserved.

Drugs 98

Drugs 98

Drug Channels

JUNE 4, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Find out during The 340B Drug Pricing Program: Trends, Controversies, and Outlook , a new live video webinar with Adam J. Click here to learn more and reserve your spot at the June 21 webinar. All rights reserved.

Hospitals 98

Hospitals Drugs Pharmacy 98

Drug Channels

MARCH 15, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He shares data from a Cardinal Health survey of biopharmaceutical companies and offers four factors to consider when evaluating your patient support program. Read on for Josh’s insights. All rights reserved.

Drugs 98

Drugs 98

Drug Channels

MAY 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The companies face renewed scrutiny from the Federal Trade Commission, the Office of Inspector General, and members of Congress. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

FEBRUARY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. As he explains, manufacturers want hub partners that can take a holistic approach and address each patient’s individual needs. Nasir also discusses how hub selection criteria are evolving. Read on for Nasir’s insights. All rights reserved.

Production 98

Production Research Drugs 98

Drug Channels

APRIL 16, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Alas, specialty pharmacies owned by the three largest pharmacy benefit managers (PBMs) have the most brass in their pocket, as they accounted for two-thirds of prescription revenues from pharmacy-dispensed specialty drugs. All rights reserved.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Marketing Hospitals 96

Drug Channels

FEBRUARY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Read on for Divya’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Therapies 98

Therapies Marketing Research Drugs 98

Drug Channels

FEBRUARY 16, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Gavin’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Drugs 98

Drugs 98

Drug Channels

JUNE 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She goes on to describe how manufacturers can overcome these challenges to improve outcomes for both patients and brands. Click here to learn more about CoverMyMeds’ technology solutions. Read on for Kristina’s insights. All rights reserved.

Production 52

Production Drugs 52

Drug Channels

DECEMBER 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. She describes how CoverMyMeds improves the patient experience by blending technology with human expertise and connection. Click here to learn about CoverMyMed’s next-generation patient support services. Read on for Kelly’s insights. d/b/a Drug Channels Institute.

Therapies 98

Therapies Production Drugs 98

Drug Channels

JANUARY 12, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Learn more about EVERSANA’s solutions from this complimentary whitepaper: Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence. Read on for the authors’ insights. All rights reserved.

Therapies 98

Therapies Drugs 98

Drug Channels

JUNE 21, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. I found Mark’s comments to be intriguing and highly provocative, so I invited him to publish an edited version exclusively here on Drug Channels. Read on for Mark’s unfiltered view of the PBM industry. All rights reserved.

Drugs 98

Drugs 98

Drug Channels

NOVEMBER 30, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then describes the SingleCare prescription discount card and Pharma Solutions , which provides manufacturers with a platform to reach patients. Click here to learn how manufacturers can advertise patient support programs at the point of purchase. Read on for Josh’s insights.

Drugs 97

Drugs 97

Drug Channels

NOVEMBER 10, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. James and Dinesh offer four trends that they predict will shape medication access in the coming years. Click here to learn about consulting services from MMIT and its sister company The Dedham Group. Read on for James’ and Dinesh’s insights. d/b/a Drug Channels Institute.

Marketing 97

Marketing Drugs 97

Quanticate

MAY 16, 2024

First developed in 2006, CDASH plays a vital role in establishing harmonized standards for the collection and submission of data from clinical studies. Clinical research thrives on standardised processes, and one crucial aspect is the adherence to the Clinical Data Acquisition Standards Harmonization (CDASH).

Clinical Research 59

Clinical Research Research 59

Drug Channels

NOVEMBER 17, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. She introduces us to ACTICS ® eAccess , EVERSANA’s technology platform for electronic prior authorization and benefits verification that can be used for both the pharmacy benefit and the medical benefit. To learn more about EVERSANA’s technology solution, schedule a live demo here.

Pharmacy 97

Pharmacy Therapies Drugs 97

Drug Channels

OCTOBER 6, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn about AssistRx’s digital intake technologies, download their case study: Digital Intake for More Meaningful Patient and HCP Interactions. Read on for Michael’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmacy 97

Pharmacy Drugs 97

Drug Channels

SEPTEMBER 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. Read on for Nasir’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals 97

Pharmaceuticals Therapies Production Research 97

Drug Channels

FEBRUARY 27, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. You can also find my daily posts at @DrugChannels on Twitter/X , where I have more than 17,400 followers. (I I recommend that you follow me on LinkedIn, because the quality of comments and engagement is much higher than they are on Twitter.

Pharmacy 95

Pharmacy Drugs Research International 95

SCIENMAG: Medicine & Health

AUGUST 21, 2023

FROM: James Urton Credit: NASA/MODIS Rapid Response Team/Goddard Space Flight Center FROM: James Urton University of Washington 206-543-2580 jurton@uw.edu (Note: researcher contact information at the end) For Immediate Release August 21, 2023 In 2006, the Tripod Complex Fire burned more than 175,000 acres in north-central Washington.

Research 87

Research Science 87

Drug Channels

APRIL 1, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. This morning’s announcement of CVS Health’s CostVantage pharmacy reimbursement model reflects the latest attempt to fix the system’s wacky economics. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach.

Pharmacy 98

Pharmacy Hospitals Pharmaceuticals Drugs 98

Drug Channels

NOVEMBER 3, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn more about the impact of hub service on brand launch success, download CareMetx’s latest report: Patient Service Trends Point the Way to Better Hub/ Provider Partnerships. Read on for Greg’s insights. d/b/a Drug Channels Institute.

Drugs 98

Drugs 98

Drug Channels

OCTOBER 20, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Melanie explains how such fulfillment tools also increase a pharmacy’s revenues and lowers its costs. Click here to learn about CoverMyMeds’ automated central fill solutions. Read on for Melanie’s insights. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Production Treatment Drugs 98

Drug Channels

JULY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Nonetheless, taxpayers—primarily via Medicare and Medicaid—will continue to dominate the employer-sponsored insurance market. Like it or not, vertically integrated insurers, PBMs, specialty pharmacies, and providers will continue to prosper.

Government 52

Government Specialty Pharmacies Pharmacy Drugs 52

Drug Channels

JUNE 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. You can donwload CareMetx’s full 2024 Patient Services Report here: Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. Read on for Nasir’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Pharmaceuticals 52

Pharmaceuticals Production Drugs 52

Agency IQ

APRIL 19, 2024

BY KIRSTEN MESSMER, PHD, RAC The EMA has published a draft revision to its 2006 guideline on product development quality considerations for inhaled and nasal products.

Production 59

Production 59

Drug Channels

APRIL 29, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. P.S. Join my nearly 55,000 LinkedIn followers for daily links to neat stuff. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Drugs 98

Drug Channels

JULY 7, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Sahil discusses how manufacturers can balance patients’ access to therapy with gross-to-net (GTN) goals. Visit [link] to learn more about how Phil helps improve the patient experience while managing GTN. Read on for Sahil’s insights. d/b/a Drug Channels Institute.

Therapies 98

Therapies Drugs 98

Drug Channels

JULY 23, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Insulin has been the first to deflate—and the Humira biosimilar market may be next. Journey with me to Bikini Bottom as we delve into the murky waters of gross-to-net drug pricing at the biggest drugmakers. All rights reserved.

Biosimilars 52

Biosimilars Pharmaceuticals Production Marketing 52